Breaking News

Home / NYT / CureVac’s mRNA vaccine reaches an efficacy of just 47 percent in a clinical trial.

CureVac’s mRNA vaccine reaches an efficacy of just 47 percent in a clinical trial.

2:27 PM

By BY CARL ZIMMER from NYT Health https://ift.tt/2S3JZhJ

No comments

Subscribe to: Post Comments ( Atom )